Home / News / Leicester healthcare provider seals health tech deal

Leicester healthcare provider seals health tech deal

Leicester-based Spirit INT, the parent company of healthcare provider Spirit Healthcare, has bought Peterborough-based healthcare technology developer Aseptika, a pioneer in the medical wearable and self-care technology sectors.

The deal, which was completed for an undisclosed value, will bring Aseptika’s Activ8rlives range of self-monitoring solutions into the Spirit stable alongside its cloud-based technology CliniTouch Vie.

Spirit’s CEO Chris Barker said: “At Spirit, we believe that we can offer patients greater control over their own health by rethinking the way that care is delivered and Aseptika shares this vision. The Aseptika team has exceptional experience developing pioneering technology and we’re looking to grow this capability at their Cambridgeshire hub. With these skills, Spirit will be able to accelerate its programme of innovation. We’re innovating and growing fast so we can empower more patients across the UK. This significant acquisition is the second that we’ve made and we’re certainly on the hunt for more acquisition opportunities in the near future.”

Aseptika founder Kevin Auton said: “We are delighted to be joining the highly successful Spirit group of companies in delivering the new technologies, solutions and services needed to support the growing healthcare needs of the UK. Spirit exemplifies the drive and innovation of the SME sector in delivering the technologies and services our NHS will need in the coming months and years as it accelerates towards digital delivery of healthcare to make its finite resources go further.

“Both companies have been extensively supported through the Small Business Research Initiative for Healthcare (SBRI Healthcare) and Innovate UK programmes. We look forward to bringing the wearable medical monitor BuddyWOTCHTM and the patented home-use test to detect bacterial chest infections to the market to support patients with severe respiratory conditions.”

Barker added: “The Spirit and Aseptika teams have already been collaborating together to develop a cutting edge mobile technology to improve management of type 1 diabetes in a research project in Scotland as part of an SBRI competition so we are excited to explore the future potential of our partnership.”

To find out more about Spirit Healthcare, please click here.

Check Also

Quotient Sciences Constructs State-of-the-Art Early-Phase Formulation and Manufacturing Facility in U.S.

Quotient Sciences, a leading drug development services organisation, announces a significant expansion to its operations …